Eli Lilly (LLY)

• Market cap: $1.1T
• 1 day: 3.9%
• 5 days: 10.25%
• 1 month: 3.65%
• 3 months: 27.4%
• 6 months: 20.19%
• Year to date: 14.03%
• 1 year: 93.94%
• 5 years: 357.21%
• 10 years: 1,429.41%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 50,000